Tindamax (tinidazole) Website references

Aimakhu V. Vaginal trichomoniasis: one stat dose of tinidazole compared with a seven day course of metronidazole. W Afr Med J. 1975 Apr;97-100.
Amebiasis [Internet]. CDC; 2004 Jan [accessed 2008 Jul 10]. Available from: http://www.cdc.gov/ncidod/dpd/parasites/amebiasis/factsht_amebiasis.htm
Amebiasis [Internet]. MedlinePlus Medical Encyclopedia; 2006 Aug 15 [accessed 2008 Jul 15]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/000298.htm
Amebic Liver Abscess [Internet]. MedlinePlus Medical Encyclopedia; 2007 Jun 29 [accessed 2008 Jul 15]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/000211.htm
Anjaeyulu R, Gupte SA, Desai DB. Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole. J Int Med Res. 1977;5(6):438-41.
Bakshi JS, Ghiara JM, Nanivadekar AS. How does tinidazole compare with metronidazole? A summary report of Indian trials in amoebiasis and giardiasis. Drugs. 1978;15 Suppl 1:33-42.
Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories;1999:1254-8.
Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007 Oct;9(5):429-33.
Beric B, Pribicevic V, Djordjevic M, Pavlovic N. Clinical studies on the therapeutic effect of tinidazole ("Fasigyn") during treatment of urogenital trichomonas infections in women and men (with comparative laboratory studies on the effect of metronidazole and tinidazole) Zentralbl Gynakol. 1978;100(24):1594-9.
The Centers for Disease Control and Prevention: Health Guide for International Travelers, 2005-2006. Available at http://www2.ncid.cdc.gov/travel/yb/utils/ybGet.asp?section=dis&obj=giardiasis.htm. Accessed January 31, 2007.
The Centers for Disease Control and Prevention: Sexually Transmitted Diseases Treatment Guidelines, 2006. Available at http://www.cdc.gov/std/treatment/2006/toc.htm. Accessed January 30, 2007.
Dan M, Sobel JD. Trichomoniasis as seen in a chronic vaginitis clinic. Infect Dis Obstet Gynecol. 1996;4(2):77-84.
Demirezen S, Korkmaz E, Beksaç MS. Association between trichomoniasis and bacterial vaginosis: examination of 600 cervicovaginal smears. Cent Eur J Public Health. 2005 Jun;13(2):96-8.
Fantini E, Leguen J, Kellemberger J, Rubi R. Treatment of trichomoniasis in males with a single dose of a new imidazole derivative. Sem Med. 1974 Jul;46-50.
Ferris DG, Hendrich J, Payne PM, Getts A, Rassekh R, Mathis D, Litaker MS. Office laboratory diagnosis of vaginitis. Clinician-performed tests compared with a rapid nucleic acid hybridization test. J Fam Pract. 1995 Dec;41(6):575-81.
Fumarola L, Francavilla A, Palasciano N, Ialongo P, Pastore G, Sforza E, Rizzo C, Di Marzo L, Monno R. Amebic liver abscess: report of three cases. Parassitologia. 2007 Jun;49(1-2):49-53.
Gabriel G, Robertson E, Thin RN. J Int Med Res. 1982;10(2):129-30. J Int Med Res. 1982;10(2):129-30.
Gazder AJ, Banerjee M. Single-dose treatment of giardiasis in children: a comparison of tinidazole and metronidazole. Curr Med Res Opin. 1977;5(2):164-8.
Giardia: Drinking Water Fact Sheet [Internet]. United States Environmental Protection Agency, Office of Water; 2000 Sept [accessed 2008 Jul 10]. Available from: http://www.epa.gov/waterscience/criteria/humanhealth/microbial/giardiafs.pdf
Giardia Infection [Internet]. CDC; 2004 [accessed 2008 July 10]. Available from: http://www.cdc.gov/ncidod/dpd/parasites/giardiasis/2004_PDF_Giardiasis.pdf
González-Gay MA, Cereijo MJ, Aguero JJ, Sánchez-Andrade A, López Roses L. [Reactive arthritis and infestation by Giardia lamblia] Rev Esp Enferm Dig. 1991 Oct;80(4):269-70.
Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis. J In Vitro Fert Embryo Transf. 1990 Jun;7(3):165-7.
Gradus MS. Water quality and waterborne protozoa. Clin Microbiol News 1989;11:121-125.
Gram IT, Macaluso M, Churchill J, Stalsberg H. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control. 1992 May;3(3):231-6.
Grazioli B, Matera G, Laratta C, Schipani G, Guarnieri G, Spiniello E, Imeneo M, Amorosi A, Focà A, Luzza F. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol. 2006 Mar 28;12(12):1941-4.
Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol. 1993 Mar 1;137(5):577-84.
Heine RP, McGregor JA, Patterson E, Draper D, French J, Jones W. Trichomonas vaginalis: Diagnosis and Clinical Characteristics in Pregnancy. Infect Dis Obstet Gynecol. 1994;1(5):228-34.
Heller DS, Maslyak S, Skurnick J. Is the presence of Trichomonas on a Pap smear associated with an increased incidence of bacterial vaginosis? J Low Genit Tract Dis. 2006 Jul;10(3):137-9.
Hepatomegaly [Internet]. MedlinePlus Medical Encyclopedia; 2007 Nov 13 [accessed 2008 Jul 15]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm
Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1992 Mar;166(3):938-44.
Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 2):455-9.
Hillström L, Pettersson L, Pálsson E, Sandström SO. Comparison of ornidazole and tinidazole in single-dose treatment of trichomoniasis in women. Br J Vener Dis. 1977 Jun;53(3):193-4.
Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999 Aug;26(7):381-7.
Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, Hobbs MM. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis. 2007 Jul 15;45(2):194-8. Epub 2007 Jun 6.
Islam N, Hasan K. Tinidazole and metronidazole in hepatic amoebiasis. Drugs. 1978;15 Suppl 1:26-9.
Jokipii L, Jokipii AM. Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects and drug absorption and elimination. J Infect Dis. 1979 Dec;140(6):984-8.
Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Comparative study of tinidazole and metronidazole in amoebic liver abscess. Curr Med Res Opin. 1977;5(2):161-3.
Krieger J, Tam M, Stevens C et al. Diagnosis of trichomoniasis, comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988;259:1223-1227.
Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB, Holmes KK. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA. 1988 Feb 26;259(8):1223-7.
Krishnamurthy KA, Saradhambal V. Single dose therapy of giardiasis: A comparative study of tinidazole and metronidazole in pediatric patients. Indian Pediatr. 1978 Jan;15(1):51-6.
Krueger A, Schulkin J, L Jones J. Survey of obstetrician-gynecologists about giardiasis. Infect Dis Obstet Gynecol. 2007;2007:21261.
Kundu SC, Sen A, Bhattacherjee TD, Dasgupta DP, Majumdar S, Moorkerjee PK, Mukerjee AB. Comparative evaluation of tinidazole and metronidazole in the treatment of amoebic liver abscess. J Ind Med Assoc. 1977 Sep 16;69(6):127-9.
Kyrönseppä H, Pettersson T. Treatment of giardiasis: relative efficacy of metronidazole as compared with tinidazole. Scand J Infect Dis. 1981;13(4):311-2.
Lehker MW, Sweeney D. Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility. Sex Transm Infect. 1999 Aug;75(4):231-8.
Livengood CH 3rd, Ferris DG, Wiesenfeld HC, Hillier SL, Soper DE, Nyirjesy P, Marrazzo J, Chatwani A, Fine P, Sobel J, Taylor SN, Wood L, Kanalas JJ. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2007 Aug;110(2 Pt 1):302-9.
Mahmoud MS, Salem AA, Rifaat MM. Human giardiasis as an etiology of skin allergy: the role of adhesion molecules and interleukin-6. J Egypt Soc Parasitol. 2004 Dec;34(3):723-37.
Manorama HT, Shenoy DR. Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J Int Med Res. 1978;6(1):46-9.
Massa M, Arias B, Subiabre V, Rojo M. Ensayo terapeutico de la infeccion por Trichomonas vaginalis en el hombre mediate una dosis unica de tinidazol. Bol Chile Parasitol. 1976 Jan-Jun;31(1-2):46-7.
Mathur SN, Itigi A, Krishnaveni, Rai V. Tinidazole and metronidazole in the treatment of amoebic liver abscess. J Int Med Res. 1977;5(6):429-33.
Mendis S, Dharmasena BD, Jayatissa SK. Comparison of tinidazole with metronidazole in the treatment of hepatic amoebiasis: a controlled double blind study. Ceylon Med J. 1984 Jun;29(2):97-100.
Misra NP, Gupta RC. A comparison of short course single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. J Int Med Res. 1977;5(6):434-7.
Moodley P, Connolly C, Sturm AW. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J Infect Dis. 2002 Jan 1;185(1):69-73. Epub 2001 Dec 4.
Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 2002 Feb 15;34(4):519-22. Epub 2002 Jan 7.
Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. Trichomoniasis and its treatment. Expert Rev Anti Infect Ther. 2006 Feb;4(1):125-35.
NIAID: bacterial vaginosis/transmission [Internet]. Bethesda: National Institutes of Allergy and Infectious Diseases; c2008 [cited 2008 Jul 23]. Available from: http://www3.niaid.nih.gov/topics/bacterialVaginosis/transmission.htm.
Nigam P, Kapoor KK, Kumar A, Sarkari NB, Gupta AK. Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole. J Assoc Physicians India. 1991 Aug;39(8):613-5.
O-Prasertsawat P, Jetsawangsri T. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis. 1992 Sep-Oct;19(5):295-7.
Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis. 1997 Sep;25(3):545-9; quiz 550.
Price MA, Zimba D, Hoffman IF, Kaydos-Daniels SC, Miller WC, Martinson F, Chilongozi D, Kip E, Msowoya E, Hobbs MM, Kazembe PN, Cohen MS. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis. 2003 Jun;30(6):516-22.
Ripa T, Weström L, Mârdh PA, Andersson KE. Concentrations of tinidazole in body fluids and tissues in gynaecological patients. Chemotherapy. 1977;23(4):227-35.
Salles JM, Moraes LA, Salles MC. Hepatic amebiasis. Braz J Infect Dis. 2003 Apr;7(2):96-110. Epub 2003 Nov 19.
Schwebke J. Understanding bacterial vaginosis: Diagnosis, treatment, and improved outcomes. J Family Prac. 2007;(suppl):1-8.
Schwebke JR, Hook EW 3rd. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis. 2003 Aug 1;188(3):465-8. Epub 2003 Jul 10.
Sexually Transmitted Diseases Treatment Guidelines 2006 [Internet]. CDC; 2006 Aug 4 [accessed 2008 Jul 18]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5511a1.htm
Sherman KJ, Daling JR, Weiss NS. Sexually transmitted diseases and tubal infertility. Sex Transm Dis. 1987 Jan-Mar;14(1):12-6.
Simjee AE, Gathiram V, Jackson TF, Khan BF. A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. S Afr Med J. 1985 Dec 21;68(13):923-4.
Singh G, Kumar S. Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amebiasis: a comparative study. Cur Med Res Opin. 1977;5(2):157-60.
Skerk V, Schönwald S, Krhen I, Markovinovic L, Beus A, Kuzmanovic NS, Kruzic V, Vince A. Aetiology of chronic prostatitis. Int J Antimicrob Agents. 2002 Jun;19(6):471-4.
Sobel JD. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896-903.
Speelman P. Single-dose tinidazole for the treatment of giardiasis. Antimicrob Agents Chemother. 1985 Feb;27(2):227-9.
Stanley SL Jr. Amoebiasis. Lancet. 2003 Mar 22;361(9362):1025-34.
Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol. 2007 Jan;37(1):11-20. Epub 2006 Oct 12.
Summary of Notifiable Diseases, United States, 1994 [Internet]. CDC; 1995 Oct 06 [accessed 2008 Jul 16]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00039679.htm
Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007 Nov 15;45(10):1319-26. Epub 2007 Oct 15.
Swami B, Lavakusulu D, Devi CS. Tinidazole and metronidazole in the treatment of intestinal amebiasis. Cur Med Res Opin. 1977;5(2):152-6.
Sweet RL. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol. 2000;8(3-4):184-90.
Taber's Cyclopedic Medical Dictionary - Ed. 20, Editor Donald Venes. F.A. Davis Company 2005.
Thornton AC, Dale T, Fortenberry D, Logan TK. Occurrence of trichomoniasis in college women [abstract]. Abstracts of the 15th ISSTDR 2003; July 27-30; Ottawa, Canada.
Trichomoniasis CDC Fact Sheet [Internet]. CDC; 2007 Dec [accessed 2008 Jul 18]. Available from: http://www.cdc.gov/STD/Trichomonas/Trichomoniasis-Fact-Sheet.pdf
Vaginitis. ACOG Practice Bulletin No. 72. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2006;107:1195-206.
van Hal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL. Amoebiasis: current status in Australia. Med J Aust. 2007 Apr 16;186(8):412-6.
Wallin J, Forsgren A. Tinidazole--a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br J Vener Dis. 1974 Apr;50(2):148-50.
Weidenbach A, Leix H. Treatment of trichomonal vaginitis with a single dose of tinidazole. Curr Med Res Opin. 1974;2(3):147-52.
Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10.
Yoder JS, Beach MJ; Centers for Disease Control and Prevention (CDC). Giardiasis surveillance--United States, 2003-2005. MMWR Surveill Summ. 2007 Sep 7;56(7):11-8.

Important Safety Information

WARNING: POTENTIAL RISK FOR CARCINOGENICITY

Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects. Its use should be reserved for the conditions described in INDICATIONS AND USAGE.

Contraindications

Prior history of hypersensitivity to tinidazole or other nitroimidazole derivatives
First trimester of pregnancy
Nursing mothers, unless breast-feeding is interrupted during tinidazole therapy and for 3 days following the last dose

Warnings and Precautions

Seizures and neuropathy have been reported. Discontinue Tindamax if abnormal neurologic signs develop
Vaginal candidiasis may develop with Tindamax and require treatment with an antifungal agent
Use Tindamax with caution in patients with blood dyscrasias. Tindamax may produce transient leukopenia and neutropenia

Adverse Reactions

Most common adverse reactions for a single 2 g dose of tinidazole (incidence >1%) are metallic/bitter taste, nausea, weakness/fatigue/malaise, dyspepsia/cramps/epigastric discomfort, vomiting, anorexia, headache, dizziness and constipation. To report SUSPECTED ADVERSE REACTIONS, contact Mission Pharmacal Company at 1-800-298-1087 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.

Please see full Prescribing Information